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1  | INTRODUC TION
Although neuroinflammation is a feature of Alzheimer’s disease,1 
the degree to which pathophysiology may be driven by systemic 
inflammation is unclear. For example, systemic illnesses with a 
pro- inflammatory response may contribute to neurodegeneration 
and worsening dementia severity.2-5 However, findings from epi-
demiological studies have been inconsistent6-11; discrepancies may 
in part reflect complexities in modelling the temporal patterns of 
modifiable life course factors on both systemic inflammation and 
cognition. These factors include educational attainment,12 body 
mass index (BMI),13 alcohol intake,14 smoking, and exercise.15 Many 
of these exposures are time- varying and so apparent associa-
tions with inflammation and cognition may be subject to reverse 
causation.
In this study, we set out to quantify the relationships among 
measures of systemic inflammation, modifiable life course factors 
known to be associated with cognitive impairment, and subsequent 
cognitive outcomes. We investigated this in a birth cohort with 
the advantage of accurate ascertainments of exposures across the 
whole life course, along with detailed assessment of cognition, to 
answer the following questions:
1. Is systemic inflammation prospectively associated with later 
cognitive impairment?
2. Is any association explained by modifiable lifestyle risk factors, 
such as early life educational attainment, body mass index, mid-
life exercise, alcohol consumption, or smoking?
2  | METHODS
2.1 | Population sample
The MRC National Survey for Health and Development (NSHD) is 
the oldest British birth cohort, following a sample of 5362 male and 
female participants born in 1 week in March 1946.16 During the 24th 
data collection in 2014- 2015, 2942 participants in the target sample 
living in England, Scotland, and Wales were contacted: 2453 (83.4%) 
returned a postal questionnaire and 2149 (73%) participants had a 
home visit by a research nurse.17 The target sample did not include 
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Abstract
Serum pro- inflammatory markers may contribute to dementia pathophysiology and 
cognitive impairment. In a population- representative birth cohort, serum C- reactive 
protein (CRP), interleukin- 6 (IL- 6), and white cell count (WCC) were measured at age 
60- 64 years and cognition was assessed using the Addenbrooke’s Cognitive 
Examination (ACE- III) at age 69 years. Higher baseline CRP and IL- 6 were associated 
with lower ACE- III scores, but associations were attenuated on adjustment for edu-
cational attainment, sex, and other modifiable life course factors. No associations 
were found for CRP, IL- 6, and WCC with visual search speed or verbal memory. In 
conclusion, the relationship between increased baseline systemic inflammation and 
poorer cognition in later life may be explained by, or share pathways with, education 
and other modifiable life course factors.
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participants no longer in the study (n = 2420): 957 (17.8% of the 
original sample) had already died, 620 (11.6%) had previously with-
drawn from the study, 448 (8.3%) had emigrated and had no contact 
with the study, and 395 (7.4%) had been untraceable for more than 
5 years.
2.2 | Outcomes: General cognition
At age 69 years, the cognitive assessments comprised the 
Addenbrooke’s Cognitive Examination, third version (ACE- III), and 
verbal memory and visual search speed tasks, carried out by a re-
search nurse according to the same standardized protocol as at ear-
lier ages.18 A customized version of the ACE- III was administered by 
iPad	(Apple)	using	ACE	Mobile	(http://www.acemobile.org/).	Of	the	
2149 participants visited by the research nurse, complete ACE- III 
data were available for 1751 participants (81.5% of those who re-
ceived a home visit).17 Verbal memory was assessed using a 15- item 
word- learning task, where each word was presented for 2 seconds. 
The score represents the total number of words correctly recalled 
over three identical trials (maximum 45). Visual search speed was 
assessed by crossing out the letters P and W, randomly embedded 
within a grid of other letters, as quickly and accurately as possible in 
1 minute. The score represents the total number of letters searched 
(maximum 600).
2.3 | Exposures: Serum inflammatory 
markers and covariates
At age 60- 64 years, participants had attended a clinic or had been 
visited by a research nurse, during which a blood sample had been 
taken. Aliquots were frozen and transferred to the MRC Human 
Nutrition Research Laboratory in Cambridge, UK, where analyses of 
inflammatory marker C- reactive protein (CRP) and white blood cells 
were processed according to standardized protocols.19 Analyses of 
interleukin- 6 (IL- 6) were further undertaken by the British Heart 
Foundation Research Centre in Glasgow, UK.
During the home or clinic visits, waist circumference, height, 
and weight were measured using standardized protocols, and BMI 
was calculated (kg/m2). Participants were asked how many times in 
the last 4 weeks they had taken part in sports or vigorous activities, 
categorized as inactive (no episodes), less active (1- 4 exercise epi-
sodes/mo),	and	more	active	(≥5	exercise	episodes/mo).	Smoking	his-
tory was prospectively self- reported and calculated as pack- years. 
Alcohol consumption was defined by frequency: four or more times 
per week; two to four times per week; two to four times per month; 
less than monthly; or a lifelong non- drinker of alcohol. Educational 
qualifications by age 26 were categorized into none or less than 
ordinary	 secondary	 level	 (“O”	 levels	 usually	 taken	 at	 age	 16);	 “O”	
levels;	and	advanced	secondary	level	(“A”	level)	and	higher.	All	data	
collected at age 60- 64 years were used to update corresponding in-
formation at earlier ages.
TABLE  1 Characteristics for NSHD participants completing 
ACE- III at 69 y
Maximum sample 
with ACE- III
NSHD age 60- 64 y
Men Women P value
n 841 910
ACE- III at 69 y 91.4 (5.64) 91.7 (6.13) 0.28
Mean visual search speed (SD)
At 69 y 256 (74) 268 (74) <0.01
At 53 y 273 (75) 289 (76) <0.01
Mean verbal memory score (SD)
At 69 y 21.1 (6.0) 23.2 (6.0) <0.01




≥A	levels 51.3 36.9 <0.01
Body mass index 
(mean, SD)
27.9 (4.1) 27.9 (5.5) 0.94
Exercise activity at 60- 64 y (%)
Never 61.3 59.3
1- 4 times/wk 14.5 15.6
≥5	times/wk 24.2 25.2 0.71




1- 5 pack- years (%) 17.3 20.9
6- 20 pack- years 
(%)
28.2 19.8
>20 pack- years (%) 25.1 17.8 <0.01
Alcohol intake at 68 y
Never 17.0 29.0
Less than monthly 5.2 8.0
2- 4 times per 
month
13.1 17.9
2- 4 times per week 28.1 22.9
4 or more times 
per week
36.6 22.3 <0.01












WCC (median, IQR) n = 683 n = 749
5.9 (5.1- 7) 5.6 (4.8- 6.7) <0.01
ACE- III, Addenbrooke’s Cognitive Examination, third version; CRP, C- 
reactive protein; IL- 6, interleukin- 6; IQR, interquartile range; NSHD, 
National Survey for Health and Development; SD, standard deviation; 
WCC, white cell count.
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2.4 | Statistical analysis
The complete sample with cognitive assessments at 69 years, serum 
inflammatory markers at 60- 64 years, and complete information on 
covariates data included 1008 participants. CRP, IL- 6, and white cell 
count (WCC) were divided into tertiles, consistent with the previous 
literature.6 All cognitive measures and continuous covariates were 
assessed for Gaussian distributions. Using a complete sample, as-
sociations between inflammatory exposures and cognition were es-
timated using univariate linear regression, then in turn adjusted for 
each selected covariate. All covariates that resulted in a change in 
model estimates when adjusted for were included in a final regres-
sion model (Table S1).
Linear regression was performed for all inflammation exposures 
and covariates with ACE- III, then adjusted for educational attain-
ment at age 26 years, then additionally adjusted for modifiable life 
course covariates. Similar models were estimated for visual search 
speed and verbal memory at 69 years, first adjusting for prior per-
formance at 53 years, then additionally for educational attainment; 
and finally, additionally for modifiable life course covariates. STATA 
version 15.1 (StataCorp) was used for all analyses.
3  | RESULTS
The prevalence of each exposure, including mean and standard devi-
ations of inflammatory markers at age 60- 64 years, in relation to the 
sample followed at age 69 years is shown in Table 1. No significant 
sex differences were observed between each inflammation marker 
and individual covariates.
3.1 | Inflammation markers
There was an association between CRP and IL- 6 with ACE- III scores 
in univariate analyses (maximum coefficients compared to refer-
ence:	CRP	−1.29	points,	IL-	6	−1.27	points;	P < 0.01). When adjusted 
for educational attainment, both associations were attenuated. 
Associations for all three inflammatory markers were further at-
tenuated when fully adjusted for other modifiable life course factors 
(Table 2). No associations for CRP, IL- 6, and WCC with visual search 
speed or verbal memory were evident either in univariate or fully 
adjusted models (Tables S2 and S3).
3.2 | Education attainment and lifestyle risk factors
Increased educational attainment, increased mid- life exercise fre-
quency, and lower mid- life alcohol intake were prospectively associ-
ated with ACE- III in fully adjusted models (fully adjusted: education 
4.70	points	[“A”	level	or	higher	vs	less	than	“O”	level,	P < 0.01]; alcohol 
1.1 points [four times per week vs none, P = 0.03]; and exercise 1.0 
points [more than five times per week vs never, P = 0.04]). Increased 
BMI at 60- 64 years was associated with ACE- III in univariate models 
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(P = 0.35; Table 2). No associations were demonstrated between ed-
ucation or modifiable life course factors with later- life visual search 
speed performance in fully adjusted models (Table S2). Educational 
attainment, exercise, alcohol intake, and smoking were associated 
with later life verbal memory performance in fully adjusted models 
(Table S3).
4  | DISCUSSION
Our	 findings	 demonstrated	 that	 associations	 between	 mid-	life	
baseline IL- 6 and CRP with later life cognitive impairment were ex-
plained by educational attainment and modifiable life course fac-
tors. Mid- life exercise, alcohol intake, and educational attainment 
were prospectively associated with domain- specific impairment in 
verbal memory but not visual search speed, independently of mid- 
life inflammation. Taken together, the relationship between systemic 
inflammation and later life cognition may be mediated by, or share 
pathways with, modifiable life course factors.
The literature on systemic inflammation, modifiable life course 
factors, and cognitive impairment has been inconsistent: While 
raised serum proinflammatory markers were prospectively as-
sociated with poorer cognitive performance in the Rotterdam,9 
Framingham,8 and American Health, Aging, Body Composition co-
horts,10 no associations were found in Dutch,7 Swedish,11 or other 
US cohorts.7,20-22 These discrepancies likely reflect differences in 
study protocols, cohort ages, secular period, ethnicities, and degree 
of adjustment by confounders.
Our	findings	are	unique	in	the	following	respects:	First,	partic-
ipants were in their seventh decade, younger than other cohorts 
and perhaps at a critical period for when dementia pathophys-
iology is being initiated.23 In addition, the ACE- III is a more de-
tailed cognitive measure compared with briefer tests used in other 
studies, such as the Mini- Mental State Examination. Nonetheless, 
our findings are limited by having a small range of serum pro- 
inflammatory markers. In common with other cohort studies, our 
results may be subject to residual confounding and are specific to 
the population and era under study. Due to sample attrition, some 
data were missing and not at random. However, although we were 
unable to account for this in our model estimates, previous anal-
yses within the NSHD cohort have shown only small differences 
between included participants and those excluded due to missing 
data.19 Multiple imputation of covariates, which can be intrinsically 
problematic, would likely result in minimal changes to the model.24 
Unavailable confounders may have additionally contributed to 
cognitive changes: these included unrecorded comorbidities, such 
as atrial fibrillation, as well as changes in lifestyle behaviors be-
tween the studied ages of 60- 64 and 69 years, during transition 
from employment to retirement. Lastly, we assumed that levels of 
systemic inflammation would correspond to central inflammation 
across the whole population. This is unlikely to be the case because 
factors like blood- brain barrier permeability are likely to vary be-
tween individuals,25 and even subclinical neurodegeneration may 
lead to microglial priming and consequent exaggeration of central 
inflammation.26
At least in NSHD, it appears the association between systemic 
inflammation and worse cognitive outcomes may be explained by: 
(a) pro- inflammatory consequences of poor health behaviors (low 
physical activity, alcohol use, smoking) and/or (b) shared pathways 
between	poor	health	behaviors	and	cognitive	impairment.	Our	find-
ings are consistent with a randomized trial that demonstrated that 
multi- domain interventions—where exercise was a key component—
resulted in cognitive benefits in older people.27 Furthermore, exer-
cise has been associated with larger hippocampal volumes, increased 
gadolinium perfusion, and improved complex object recognition.28 
Exercise is likely to be beneficial in reducing the vascular contribu-
tions to cognitive impairment from metabolic abnormalities, such as 
insulin resistance.
Despite these findings in the general population, there remains a 
case for investigating the relationship between systemic inflamma-
tion and neurodegeneration. Firstly, a wider panel of serum markers 
across the inflammatory cascade requires more detailed examina-
tion. Blood- brain barrier dynamics linking serum and CNS inflamma-
tion also merits study, perhaps in the context of acute illnesses, such 
as delirium. Such a paradigm would investigate if different inflamma-
tory burdens during acute illnesses contribute differently towards 
mechanisms in delirium and dementia and hence, variable dementia 
risks.29 An understanding of how systemic inflammation contributes 
to neurodegeneration, and their relation to already identified life 
course risk factors, might therefore implicate novel pathways to-
wards modification of the course of Alzheimer’s disease and other 
dementias.
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